In various types of cancers including glioma, PD-L1 plays a major inhibitory role in modulating infiltration of immune cells, such as CTL, tumor infiltrating lymphocytes (TIL) and regulatory T-lymphocytes (Treg) (Taube et al., 2012; Dong et al., 2017). The gene discussed is CD274; the disease is cancer.